On September 15, we hosted our first conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry. We were thrilled to have more than 120 participants from over 40 different companies, who were able to enjoy our diverse program with ample networking opportunities. If you couldn’t make it or would like to relive the day, have a look at our aftermovie to take in some of the innovative atmosphere we witnessed that day!
Category: Program
Conference opening, introductions and keynote
9h00: Registration
9h30
Welcome & conference opening
Rik Van de Walle, Rector UGent
9h40
Introduction to CESPE
Prof. Thomas De Beer, CESPE Director
10h00
Flanders R&D policies for better health and care – Towards Recovery Resilience
Kathleen D’Hondt, Policy Analyst, Department Economy, Science and Innovation – Flemish Government
10h15
Keynote ‘Healthcare Innovation: the crossroads of HealthTech and the (bio)pharmaceutical ecosystem’
Ann Van Gysel, CEO Medvia
10h45
Break (posters & exhibition booths)
Chemical drug substance manufacturing of the future
11h05
Drug Substance Manufacturing in 2030 – adaptive, connected & sustainable
Yves Vancleemput, Director Business Development, Janssen Pharmaceutica
11h20
The Future will flow, more and more in the pharmaceutical sector
Prof. Chris Stevens, UGent
11h35
Design of Sustainable Pharmaceutical Processes with Artifcial Intelligence
Maarten Dobbelaere, UGent
Biopharmaceuticals: a fast growing pipeline
11h50
Setting up a large scale clinical and commercial CAR-T manufacturing HUB in Ghent
Birk Vanderweeën, General Manager Europe, Legend Biotech
12h10
Networking lunch (posters & exhibition booths)
13h25
Continuous manufacturing of antibodies: the inevitable step towards sustainable drug manufacturing
Koen Dierckx, CEO SimAbs
13h40
Discovery and selection of therapeutic antibodies with drug-like properties
Prof. Hristo Svilenov, UGent
13h55
An academic’s journey to spin-out commercialization of a new manufacturing technology: continuous pharmaceutical lyophilization
Prof. Thomas De Beer, UGent & RheaVita
Towards efficient Drug Product Development & Controlled Manufacturing
14h10
Challenges and opportunities in drug product development
Fanny Stauffer, Drug Product Expert, UCB
14h30
Linking material proporties to their behavior during processing
Prof. Chris Vervaet, UGent
Process simulation & sustainable systems engineering as key element for future proof pharmaceutical manufacturing
14h45
Advanced process simulation for smart manufacturing process development, scale-up and operation
Wim Audenaert, CEO & Co-founder AM-Team
15h00
Sustainability Assessment in the pharmaceutical sector
dr. Lieselot Boone, UGent
15h15
Break (posters & exhibition booths)
(Bio)pharmaceutical manufacturing; staying ahead of what’s next
15h45
Panel discussion
Ann Van Gysel, CEO Medvia
Claire Skentelbery, Director General EuropaBio
Yves Vancleemput, Director Business Development, Janssen Pharmaceutica
Birk Vanderweeën, General Manager Europe, Legend Biotech
Prof. Thomas De Beer, CESPE Director
(moderation: Tineke Van hooland)
16h30
Pech Kucha presentations
Closing
17h45
Closing word
Sofie Bracke, Executive Councillor for Economy, Port and Sports, City of Ghent
Wouter De Soete, Manager CESPE
Christoph Portier, CESPE Operations Manager
Networking reception & Dinner
18h00 – 22h00
(posters & exhibition booths)
On this page you will find all the updates considering the program of our CESPE conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry. At this event, there will be a mix of senior industry leaders, policy makers, academics and startups. There will be a variety of talks on chemical drug substance, drug product and biotech manufacturing, providing insights in both industrial and academic state-of-the-art. There will also be ample opportunities to network with all participants.
What’s in it for you?
You will:
- Have access to state-of-the-art science in the field of chemical drug substance, drug product and biotech manufacturing
- Get to know groundbreaking and disruptive manufacturing technologies
- Expand your professional network
- Learn more about our new facilities planned at Tech Lane Ghent Science Park, including cleanrooms to handle potent APIs
- Have the latest insights in the new Master in Pharmaceutical Engineering, unique in Flanders and launched in September ’22.
- Have discussion opportunities with talented PhD and postdoctoral researchers through interactive poster sessions
- Learn about access to young talent through various master thesis opportunities
We are excited to announce Dr. Ann Van Gysel as keynote speaker at our CESPE Conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry on September 15th in Ghent! Dr. Van Gysel was recently appointed as CEO of the spearhead cluster MEDVIA. In her keynote, she will focus on the current trends in healthcare and the (bio)pharmaceutical landscape.
Ann Van Gysel has always been passionate about innovation in healthcare. She started out as a biologist and received her PhD in molecular biology from the University of Gent. She acquired post-graduate degrees in Business Management and Marketing and Communications. In 2009, she joined FlandersBio as Managing Director. During her three-year tenure, she doubled the number of members, putting Flanders on the international map as a one of the major biotech hubs. In 2011, Ann founded Turnstone Communications, a consultancy agency providing communications and marketing services to healthcare, life sciences and pharmaceutical organizations in Belgium and abroad. She was the founder of the digital life sciences news platform BioVox.eu, sharing Belgian innovations with national and international professionals. Since January 2022 she has been the CEO of MEDVIA, a public-private partnership founded by the Flemish Government to support innovation in healthcare focusing on biotech, medtech and digital health.
